ATMP | Pharmaceuticals | Regulatory Rapporteur

Skip to main content
Skip to navigation

Advanced Therapy Medicinal Products

HM9: From barrier to bridge – Practical strategies for successful advanced therapy medicinal product (ATMP) development
2025-11-18T09:57:00+00:00
HM4: Revision of the EU Variation Regulation – Continuing innovation in lifecycle management
2025-11-18T09:55:00+00:00
November 2025 – Contents: Medical devices/IVD sessions
2025-11-17T17:58:00+00:00
November 2025 – Contents: Human medicines sessions
2025-11-17T15:42:00+00:00
Regulatory Rapporteur November 2025 – Contents
2025-11-17T15:09:00+00:00
ICH Q1 guideline revisions to promote innovation and enable global patient access to high-quality medicines
2025-10-10T11:14:00+01:00

Regulatory Rapporteur October 2025 – Contents
2025-10-09T15:33:00+01:00
FAMHP: The role of the Belgian Agency in advancing public health
2025-06-20T14:56:00+01:00
RegRapPod − InConversation with Hugues Malonne
2025-06-18T16:55:00+01:00
Recent advances and the near-term outlook for Advanced Therapy Medicinal Products in cancer treatment
2025-05-02T13:41:00+01:00
Case studies: The impact of the In Vitro Diagnostic Regulation on ATMP clinical trials and drug development plans
2025-05-02T13:41:00+01:00
May 2025 – Contents
2025-05-01T14:56:00+01:00

More ATMP content